Clinical Trial Update: Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention

View source ↗

Summary

A clinical trial update examining the molecular effects of a new multi-carotenoids agent (MCS) for chemoprevention of prostate cancer; the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Multi-carotenoids (MCS) New Agent (multi-carotenoids agent)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Prostate Cancer | Status: UNKNOWN